Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery. J Nanosci Nanotechnol. 2006;6:2651-2663.Chavanpatil MD, Khdair A, Panyam J (2006) Nanoparticles for cellular drug delivery: Mechanisms and factors influencing delivery. J Nanosci Nanotechnol 6: 2651-2663....
B. Active cellular and subcellular targeting of nanoparticles for drug delivery. Pharmaceutics 11, 543 (2019). CAS PubMed Central Google Scholar Oliva, N. et al. Regulation of dendrimer/dextran material performance by altered tissue microenvironment in inflammation and neoplasia. Sci. Transl. Med....
In addition, by using activator or inhibitor of P2X7R, they showed an efficient way to decrease or increase the amount of SWCNTs inside cells, making it potentially useful for controlling the drug delivery efficacy and toxicity of nanocarriers. Since P2X7R activation also induces the secretion of...
By definition, these constructs and assemblies are nanoscale and include entities such as drugs, proteins, DNA/RNA, viruses, cellular lipid bilayers, cellular receptor sites and antibody variable regions critical for immunology and are involved in events of nanoscale proportions. The emergence of such...
摘要: The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one bioactive agent for treating wet AMD. The nanoparticles are characterized with a positive surface charge and their enhanced permeability for paracellular drug delivery....
AE Gregory,R Titball,D Williamson - 《Frontiers in Cellular & Infection Microbiology》 被引量: 288发表: 2013年 Nanoparticles and microparticles as vaccine-delivery systems Vaccine-delivery systems are generally particulate (e.g., emulsions, microparticles and liposomes) and have comparable dimensions to...
Nanotechnology in cancer therapeutics: Bioconjugated nanoparticles for drug delivery Nanotechnology refers to the interactions of cellular and molecular components and engineered materials-typically, clusters of atoms, molecules, and molecu... R Sinha,GJ Kim,S Nie,... - 《Molecular Cancer Therapeutics》...
Nanoparticles-mediated CRISPR-Cas9 gene therapy in inherited retinal diseases: applications, challenges, and emerging opportunities Yueh Chien Yu-Jer Hsiao Yi-Ping Yang Journal of Nanobiotechnology (2022) Efficiency of Chitosan-Coated PLGA Nanocarriers for Cellular Delivery of siRNA and CRISPR/Cas9 Comp...
RNA interference (RNAi) can mediate gene-silencing by knocking down the expression of a target gene via cellular machinery with much higher efficiency in contrast to other antisense-based approaches which represents an emerging therapeutic strategy for combating cancer. Distinct characters of nanoparticles...
6 PGNPs delivery of antibiotics reduces the microbiota alteration in small intestine. C57BL/6 mice were orally administered with free or ampicillin (20 mg kg−1) and vancomycin (20 mg kg−1)-loaded PGNPs for 5d. Control mice had no antibiotic exposure. Both SI-P and SI-D ...